نتائج البحث 131-140 من 8416 لعملية البحث عن Anal+cancer
... tumor DNA (ctDNA) positive, surgically resected Stage II/III rectal cancer, or Stage II (high risk)/Stage III colon cancer. A Study to Evaluate a Virtual ...
The objectives of this study are to genomically characterize patient-derived organoids (PDOs) and primary tissues from colorectal peritoneal cancer (CRC) ...
Colon cancer, Pancreatic cancer, Esophageal cancer, Liver cancer, Stomach cancer, Anal cancer, Small bowel cancer. Allon Kahn, M.D..
... tumor DNA (ctDNA) positive, surgically resected Stage II/III rectal cancer, or Stage II (high risk)/Stage III colon cancer. A Study to Compare Nivolumab ...
therapy, Colon cancer, Rectal cancer, Pancreatic cancer, Esophageal cancer, Cholangiocarcinoma, Stomach cancer, Anal cancer, Hepatocellular carcinoma. إظهار ...
The purpose of this study is to examine the needs and gap in our understanding of financial burden experienced by rectal cancer patients from a patient ...
In this study, participants with MSI-H or dMMR advanced colorectal carcinoma will be randomly assigned to receive either pembrolizumab or the Investigator's ...
Active surveillance, Ulcerative colitis, Crohn's disease, Colon cancer, Rectal cancer, Colon polyps, Diverticulitis, An...al fistula. إظهار المزيد من مجالات ...
Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...
... tumor DNA (ctDNA) positive, surgically resected Stage II/III rectal cancer, or Stage II (high risk)/Stage III colon cancer. A Study of Patients Undergoing ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.